Evaluation of the Patient and Decision Making in Anterior Lamellar Keratoplasty






art


3


Evaluation of the Patient and Decision Making in Anterior Lamellar Keratoplasty


Ashiyana Nariani, MD, MPH; Terry Kim, MD; Melissa B. Daluvoy, MD; and Alan N. Carlson, MD


Since the work done by Eduard Zirm in 1905 with the first successful human full-thickness penetrating keratoplasty (PK),1 there have been several surgeons, including von Hippel,2 Paufique and Charles,3 McGhee, Kim, and Wilson,4 and Anwar,5 who have innovated lamellar corneal transplant surgery as a potential alternative to PK for a variety of indications (Table 3-1).510


ADVANTAGES


Deep anterior lamellar keratoplasty (DALK) has emerged in recent years as a preferred approach to conserve the host endothelium and to avoid rejection.4 A report by the American Academy of Ophthalmology, in which 11 published studies comparing DALK with PK were analyzed, substantiated that DALK is superior to PK for preservation of endothelial cell density (ECD), avoiding risk of endothelial cell immune graft rejection and has additional theoretic safety advantages. There was no significant difference in best spectacle-corrected visual acuity, spherocylindrical refraction, nor postoperative astigmatism.514


Additional advantages of DALK over PK include enhanced structural integrity with less risk of rupture post-trauma,1520 faster recovery time with earlier visual improvement,21 absence of endothelial graft rejection, increased intraocular stability during surgery,22 reduced risk of choroidal hemorrhage and endophthalmitis, absence of need of donor graft with good endothelial count, better long-term graft survival,23 no late failures, minimal steroid-related complications and easier follow-up.5,24



DISADVANTAGES


Despite the advantages of the DALK procedure, the technical challenges of and additional time required for the procedure prevent some surgeons from attempting it. Some argue that higher-order aberrations and light scatter caused by the surgical interface may be factors limiting post-DALK visual outcomes.26


In order to optimize resource expenditure, it is critical to understand the indications for and contraindications to performing DALK. For those patients where both DALK and PK are viable surgical options, DALK should be attempted as the benefits of attempting the DALK procedure outweigh the risks and is in the best interest of the patient.


INDICATIONS


DALK is the preferred corneal transplant procedure of choice, over PK, for the optical correction of axial corneal diseases with intact DM and healthy corneal endothelium (see Table 3-1).510 Indications can be classified into the following categories: ectasia (Figure 3-1), superficial corneal dystrophies (Figure 3-2), corneal degenerations (Figure 3-3) and deposits (Figure 3-4), and superficial corneal scars.11



art


Figure 3-1. Keratoglobus. (Reprinted with permission from Melissa B. Daluvoy, MD, Duke University Eye Center, Durham, NC.)


 



art


Figure 3-2. Lattice corneal dystrophy. (Reprinted with permission from Melissa B. Daluvoy, MD, Duke University Eye Center, Durham, NC.)


 



art


Figure 3-3. (A) Salzmann’s nodular degeneration with corresponding (B) slit lamp examination. Reprinted with permission from Melissa B. Daluvoy, MD, Duke University Eye Center, Durham, NC.)


 



art


Figure 3.4. Cloudy cornea due to Hurler’s syndrome (Mucopolysaccharidosis Type 1). (A) Preoperative and (B) postoperative after DALK procedure. (Reprinted with permission from Melissa B. Daluvoy, MD, Duke University Eye Center, Durham, NC.)


Special Considerations


Beyond the previously mentioned indications, there are special cases in patients with healthy endothelium where DALK is the definitive treatment of choice. Surgeons not performing DALK should refer to seasoned DALK surgeons the following case scenarios:




art


Figure 3-5. (A) Corneal cystinosis deposits, extending through all corneal layers on (B) slit lamp examination and (C) anterior segment optical coherence tomography (ASOCT). (Reprinted with permission from Melissa B. Daluvoy, MD, Duke University Eye Center, Durham, NC.)

Stay updated, free articles. Join our Telegram channel

Mar 29, 2020 | Posted by in OPHTHALMOLOGY | Comments Off on Evaluation of the Patient and Decision Making in Anterior Lamellar Keratoplasty

Full access? Get Clinical Tree

Get Clinical Tree app for offline access